Research Spotlight: Advancing Neonatal Health & AMR Genomics in Cameroon
We are proud to announce that Dr Luria Founou, PhD our Head of Research has been awarded the Cambridge-Africa ALBORADA Research Fund 2025/2026 for the project entitled “Building Capacity for Facility-Based Genomic Surveillance to Curb Neonatal Sepsis and Antimicrobial Resistance in Cameroon (#BEACON)”. The #BEACON project will strengthen facility-based Genomics surveillance to improve early detection,
MILESTONE ACHIEVED: Training the Next Generation in Long-Read Sequencing Technology in Cameroon!
We are proud to celebrate the successful completion of the highly anticipated #MinION Long-Read Sequencing Workshop: “From Culture to Genotype,” which ran from December 1st to December 9th, 2025, at the CEDBCAM Research Institute (CEDBCAM-RI) in Yaoundé, Cameroon! This comprehensive 9-day training was a cornerstone activity of the #BANTU Project, which was awarded to Dr.
Celebrating a Major Achievement: CEDBCAM-RI Research Fellow Awarded Prestigious ARES PhD Scholarship
We are thrilled to announce a significant achievement by one of our exceptional research fellows, Ange Atsafack, from the CEDBCAM Research Institute (CEDBCAM-RI). Ange has been awarded the highly competitive Belgium ARES Fund PhD Scholarship at the University of Liège, where she will be supervised by Raspail Carrel Founou Zangue Ph.D. This prestigious scholarship is
Antimicrobial awareness week
CEDBCAM representatives were invited to participate and contribute to the Call to Action on AMR conference in 2021 as well as to the African World Antimicrobial Awareness Week 2021.
International Microbiology Day of the Cameroon Society of Microbiology
CEDBCAM researchers were delighted to participate to the 1st International Microbiology Day, under the theme “Antimicrobial Resistance: The Next Pandemic?” that was hosted by the Cameroonian Society of Microbiology in November 2021. From the General Director, Dr Raspail Founou as moderator, to researchers and trainees as guest speakers or presenters, the CEDBCAM Research Institute team made significant contributions
The COVID-19 pandemic: a threat to antimicrobial re-sistance containment
As of 23 April 2021, the of COVID-19 claimed around 150 million confirmed cases with over 3 million deaths worldwide. Yet, an even more serious but silent pandemic, that of antimicrobial resistance (AMR), is likely complicating the outcome of COVID-19 patients. Dr Raspail Founou and colleagues discussed the current knowledge on the emergence of the and highlights the
Methicillin resistant staphylococci isolated in clinical samples: a 3-year retrospective study analysis
Fouloum and colleagues determined the prevalence and described the antimicrobial resistance patterns of circulating methicillin-resistant staphylococci (MRS) isolated from clinical specimens during a 3-year period in CEDBCAM. From January 2017 to December 2019, 1683 clinical samples were plated onto Mannitol salt agar. Bacterial identification was performed followed by CEDBCAM researchers. Data were analyzed using R and Inzight. Staphylococci
CEDBCAM part of SEDRIC Think Tank
CEDBCAM is happy to announce that we are now member of the prestigious global think tank SEDRIC that promotes the power of data to contain antimicrobial resistance. We will bring our multi-sectorial expertise to identify evidence gaps, describe solutions and advocate for evidence-based policies and research changes in Africa. Please read more about SEDRIC here